Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-29

FDA Approved: DESVENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries' supplemental application for desvenlafaxine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine (Desvenlafaxine)

Snippet

SUPPL AP for DESVENLAFAXINE (DESVENLAFAXINE)